Adding liraglutide to continuous subcutaneous insulin infusion significantly reduces glycated hemoglobin without increasing hypoglycemia in overweight and obese people with type 1 diabetes and suboptimal glycemic control, Danish research shows.
Frequent fluctuations in glycated hemoglobin levels between clinic visits are associated with death, cardiovascular disease, and microvascular complications in patients newly diagnosed with type 2 diabetes, a Scottish study suggests.
Dapagliflozin treatment significantly improves self-reported symptoms, physical function, and quality of life in people who have heart failure with reduced ejection fraction, report the DAPA-HF investigators.
A post-hoc analysis of data from the DAPA-HF trial indicates that the sodium-glucose cotransporter 2 inhibitor dapagliflozin has consistent efficacy and safety profiles among people with heart failure and reduced ejection fraction across a range of age categories.
Elevated fasting plasma glucose is associated with a higher risk for babies born large‐for‐gestational‐age and for hypertensive disorders of pregnancy than elevated post‐load glucose in women with gestational diabetes, population-based study data show.
Islet autoantibody negativity plus mild hyperglycemia and a family history of diabetes can be used to identify children newly diagnosed with diabetes who should undergo genetic testing for maturity-onset diabetes of the young, study findings indicate.
A study of more than a thousand patients suggests that having both diabetic ketoacidosis and a hyperosmolar hyperglycemic state on arrival at hospital leads to more than twice the likelihood of death there than either condition alone.
People who are trying to maintain weight loss with the help of electronic health records-based tracking tools do significantly better if they are given access to an online coach, shows a randomized trial.
Routine echocardiographic measures of myocardial dysfunction improve on the ability of clinical risk factors to predict major adverse cardiovascular events in people with type 1 diabetes, say researchers.
The reduced prostate cancer risk seen in men with diabetes may be partly explained by detection bias due to a lower biopsy rate following an elevated prostate-specific antigen test result, population-based study data show.
Adding intensive weight management to group medical visits for type 2 diabetes leads to greater weight loss, reduced medication use, and fewer hypoglycemic events, with a similar improvement in glycemic control, research shows.
Apparent treatment-resistant hypertension may help identify patients with type 2 diabetes who are at elevated cardiovascular risk, say researchers, but ambulatory blood pressure should still be performed for comprehensive risk stratification.
People with obesity and type 2 diabetes who undergo gastric bypass surgery have higher rates of diabetes remission after 1 year than those undergoing sleeve gastrectomy, indicate findings from the Oseberg trial.
Research suggests that individuals with adult-onset type 1 diabetes could benefit from more intense monitoring, as only a minority meet recommended targets for glycemic control despite initial improvements, while at the same time the majority become overweight or obese.